• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    7/16/24 1:06:26 PM ET
    $AEON
    $AMIX
    $ANGO
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $AEON alert in real time by email

    Shares of The Charles Schwab Corporation (NYSE:SCHW) fell sharply during Tuesday's session following second-quarter results.

    Charles Schwab said adjusted net income declined 2% Y/Y to $1.465 billion. Adjusted EPS fell 3% Y/Y to 73 cents, beating the consensus of 72 cents, according to data from Benzinga Pro.

    Charles Schwab shares dipped 7.5% to $69.42 on Tuesday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • Yoshitsu Co., Ltd (NASDAQ:TKLF) jumped 109% to $0.6437 after the company reported a year-over-year increase in FY24 financial results.
    • Silo Pharma, Inc. (NASDAQ:SILO) shares climbed 95.4% to $2.12 after the company obtained an exclusive global license to develop, manufacture, and commercialize its Alzheimer’s drug.
    • Logistic Properties of the Americas (NYSE:LPA) shares climbed 53.8% to $23.71.
    • NaaS Technology Inc. (NASDAQ:NAAS) gained 38% to $3.8503.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) gained 38% to $1.4799.
    • AEON Biopharma, Inc. (NYSE:AEON) shares rose 29.2% to $2.9450 after jumping around 63% on Monday.
    • Conduit Pharmaceuticals Inc. (NASDAQ:CDT) gained 27.3% to $0.3055 after declining over 8% on Monday.
    • AngioDynamics, Inc. (NASDAQ:ANGO) surged 24.7% to $7.39 after the company reported better-than-expected fourth-quarter financial results and issued FY25 guidance.
    • KWESST Micro Systems Inc. (NASDAQ:KWE) gained 22.8% to $0.4160
    • Zenvia Inc. (NASDAQ:ZENV) climbed 22.7% to $1.9634. The company announced that it entered into an agreement with Alliance Global Partners to offer and sell Class A common shares up to $20 million.
    • Locafy Limited (NASDAQ:LCFY) rose 21% to $4.4150.
    • SciSparc Ltd. (NASDAQ:SPRC) gained 20% to $1.0150.
    • Koss Corporation (NASDAQ:KOSS) rose 19.8% to $10.45.
    • Alpha Technology Group Limited (NASDAQ:ATGL) climbed 19.2% to $3.42.
    • Meiwu Technology Company Limited (NASDAQ:WNW) shares rose 16.1% to $1.01 after surging around 15% on Monday.
    • NetSol Technologies, Inc. (NASDAQ:NTWK) climbed 16% to $3.0501 as the company signed a $16 million agreement with a major automaker to revolutionize digital car buying and leasing experience in the United States.
    • Chegg, Inc. (NYSE:CHGG) gained 15% to $3.6440. Morgan Stanley analyst Josh Baer upgraded Chegg from Underweight to Equal-Weight and lowered the price target from $6.5 to $3.25.
    • 8×8, Inc. (NASDAQ:EGHT) gained 13.3% to $2.8450. 8×8. secured a $200 million term loan at reduced interest rate.
    • Fate Therapeutics, Inc. (NASDAQ:FATE) gained 12.8% to $4.39.
    • Pacific Biosciences of California, Inc. (NASDAQ:PACB) rose 12.8% to $1.8350. PacBio is expected to hold its quarterly conference call to discuss its second quarter financial results on Wednesday, Aug. 7.
    • Newegg Commerce, Inc. (NASDAQ:NEGG) gained 11.8% to $1.14.
    • Harmony Gold Mining Company Limited (NYSE:HMY) jumped 11.8% to $10.57
    • Sana Biotechnology, Inc. (NASDAQ:SANA) surged 11.7% to $7.11.
    • ServisFirst Bancshares, Inc. (NASDAQ:SFBS) climbed 10.8% to $78.60 after the company reported better-than-expected second-quarter financial result. Also, Piper Sandler maintained a Neutral rating on the stock and raised its price target from $63 to $70.
    • Match Group, Inc. (NASDAQ:MTCH) rose 7.9% to $34.54 after Starboard Value sent a letter to the company outlining initiatives for improving growth, profitability and capital allocation.
    • Arvinas, Inc. (NASDAQ:ARVN) gained 7.7% to $32.27.
    • Shopify Inc. (NYSE:SHOP) shares rose 7.3% to $68.92 after B of A Securities upgraded the stock from Neutral to Buy.

    Losers

    • Cyngn Inc. (NASDAQ:CYN) shares fell 22.1% to $7.15 after jumping 54% on Monday.
    • Autonomix Medical, Inc. (NASDAQ:AMIX) shares declined 21.4% to $1.08. Autonomix shares jumped 130% on Monday after the company entered into an agreement with RF Innovations to license intellectual property for its Apex 6 Radiofrequency Generator.
    • Zeo Energy Corp. (NASDAQ:ZEO) fell 18% to $3.23.
    • Clearmind Medicine Inc (NASDAQ:CMND) fell 16.7% to $1.85. Clearmind Medicine announced the FDA clearance for IND application of MEAI-based CMND-100 oral capsule.
    • Crown LNG Holdings Limited (NASDAQ:CGBS) declined 15.8% to $2.65.
    • Funko, Inc. (NASDAQ:FNKO) shares fell 13.3% to $8.71.
    • Shapeways Holdings, Inc. (NASDAQ:SHPW) fell 13.2% to $0.3010.
    • Vicinity Motor Corp. (NASDAQ:VEV) shares dipped 12.8% to $0.5581 after dipping 10% on Monday.
    • Trump Media & Technology Group Corp. (NASDAQ:DJT) shares fell 8.7% to $37.04. Trump Media & Technology Group shares jumped over 31% on Monday following the attempted assassination of Donald Trump.
    • Greenpro Capital Corp. (NASDAQ:GRNQ) shares fell 8.5% to $1.08. Greenpro Capital shares surged around 35% on Monday after the company announced that its subsidiary, Green-X, secured over $100 million in digital assets.
    • Grom Social Enterprises, Inc. (NASDAQ:GROM) shares declined 7.8% to $0.3945 after gaining around 10% on Monday.
    • Reddit, Inc. (NYSE:RDDT) fell 7.1% to $67.83 after Loop Capital downgraded the stock from Buy to Hold.
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) fell 7% to $1.9150.

    Now Read This:

    • Jim Cramer Says If You Sell This Chinese EV Stock Now, ‘Some Clown’ Will Be ‘Real Positive About It,’ Wait Until ‘All That Stuff Happens‘
    Get the next $AEON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEON
    $AMIX
    $ANGO
    $ARVN

    CompanyDatePrice TargetRatingAnalyst
    Shopify Inc.
    $SHOP
    3/12/2026$165.00Overweight
    Piper Sandler
    Pacific Biosciences of California Inc.
    $PACB
    3/6/2026$1.50Equal Weight → Underweight
    Barclays
    Eos Energy Enterprises Inc.
    $EOSE
    2/27/2026$20.00Buy → Neutral
    Guggenheim
    ServisFirst Bancshares Inc.
    $SFBS
    2/27/2026$92.00 → $97.00Outperform
    Hovde Group
    Shopify Inc.
    $SHOP
    2/17/2026$150.00Hold → Buy
    Truist
    Shopify Inc.
    $SHOP
    2/12/2026$150.00Neutral → Outperform
    Mizuho
    Shopify Inc.
    $SHOP
    2/12/2026$159.00Hold → Buy
    TD Cowen
    Shopify Inc.
    $SHOP
    2/10/2026$150.00Neutral → Buy
    MoffettNathanson
    More analyst ratings

    $AEON
    $AMIX
    $ANGO
    $ARVN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Farrell Sarah E bought $1,388,730 worth of shares (10,500 units at $132.26) (SEC Form 4)

    4 - Reddit, Inc. (0001713445) (Issuer)

    3/17/26 7:20:55 PM ET
    $RDDT
    EDP Services
    Technology

    Director Urban David bought $100,100 worth of shares (16,250 units at $6.16), increasing direct ownership by 35% to 62,471 units (SEC Form 4)

    4 - Eos Energy Enterprises, Inc. (0001805077) (Issuer)

    3/10/26 8:52:43 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Director Morrison Briggs bought $268,070 worth of shares (20,000 units at $13.40), increasing direct ownership by 26% to 96,021 units (SEC Form 4)

    4 - ARVINAS, INC. (0001655759) (Issuer)

    3/9/26 4:05:21 PM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEON
    $AMIX
    $ANGO
    $ARVN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Newegg Expands Trade-In Program to Include Desktop Memory

    Newegg Commerce, Inc. (NASDAQ:NEGG), a global leader in computer and technology products, today announced the expansion of its Trade-In Program to include eligible desktop memory. The new Memory Trade-In Program allows customers to trade in qualifying DDR4 and DDR5 desktop memory kits and receive credit toward the purchase of new memory on Newegg.com. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260319886708/en/Newegg Launches Memory Trade-In Program The expansion builds on the success of Newegg's GPU Trade-In Program launched in 2023 and the CPU Trade-In Program introduced in 2024, further enhancing Newegg's ecosystem for upg

    3/19/26 9:00:00 AM ET
    $NEGG
    Other Specialty Stores
    Consumer Discretionary

    Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder

    Vancouver, Canada, March 19, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the successful continuation of treatment of participants in the third cohort of its ongoing FDA-approved Phase I/IIa clinical trial evaluating CMND-100, the Company's proprietary non-hallucinogenic MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD). This positive progress follows the Company's recent announcement on March

    3/19/26 8:45:00 AM ET
    $CMND
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Schwab Announces Its Spring Business Update

    The Charles Schwab Corporation announced today that it has scheduled a Spring Business Update for institutional investors on Thursday, April 16th. This Update, which will be held via live public webcast, is part of an ongoing series designed to help the investment community keep abreast of recent developments and management's strategic focus areas. The program is scheduled to run from 7:30 a.m. - 8:30 a.m. CT, 8:30 a.m. - 9:30 a.m. ET. Participants will include President and Chief Executive Officer Rick Wurster and Chief Financial Officer Mike Verdeschi. The Update will be accessible at https://schwabevents.com/corporation. About Charles Schwab The Charles Schwab Corporation (NYSE:SCH

    3/19/26 8:45:00 AM ET
    $SCHW
    Investment Bankers/Brokers/Service
    Finance

    $AEON
    $AMIX
    $ANGO
    $ARVN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler resumed coverage on Shopify with a new price target

    Piper Sandler resumed coverage of Shopify with a rating of Overweight and set a new price target of $165.00

    3/12/26 8:55:08 AM ET
    $SHOP
    Computer Software: Prepackaged Software
    Technology

    Pacific Biosciences downgraded by Barclays with a new price target

    Barclays downgraded Pacific Biosciences from Equal Weight to Underweight and set a new price target of $1.50

    3/6/26 8:26:02 AM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Eos Energy downgraded by Guggenheim with a new price target

    Guggenheim downgraded Eos Energy from Buy to Neutral and set a new price target of $20.00

    2/27/26 8:28:11 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    $AEON
    $AMIX
    $ANGO
    $ARVN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Wu Paul

    3 - Newegg Commerce, Inc. (0001474627) (Issuer)

    3/19/26 12:12:52 PM ET
    $NEGG
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 3 filed by new insider Hou Montaque

    3 - Newegg Commerce, Inc. (0001474627) (Issuer)

    3/19/26 12:09:09 PM ET
    $NEGG
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 3 filed by new insider Galkin Vladimir

    3 - Newegg Commerce, Inc. (0001474627) (Issuer)

    3/19/26 11:53:05 AM ET
    $NEGG
    Other Specialty Stores
    Consumer Discretionary

    $AEON
    $AMIX
    $ANGO
    $ARVN
    SEC Filings

    View All

    SEC Form 15-12G filed by Zenvia Inc.

    15-12G - Zenvia Inc. (0001836934) (Filer)

    3/19/26 1:33:51 PM ET
    $ZENV
    Computer Software: Prepackaged Software
    Technology

    SEC Form 6-K filed by Meiwu Technology Company Limited

    6-K - Meiwu Technology Co Ltd (0001787803) (Filer)

    3/19/26 9:05:06 AM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    CDT Equity Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - CDT Equity Inc. (0001896212) (Filer)

    3/18/26 4:53:07 PM ET
    $CDT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEON
    $AMIX
    $ANGO
    $ARVN
    Leadership Updates

    Live Leadership Updates

    View All

    AEON Biopharma Appoints John Bencich as Chief Financial Officer

    IRVINE, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE:AEON), a biopharmaceutical company advancing ABP-450 (prabotulinumtoxinA) as a biosimilar to BOTOX® (onabotulinumtoxinA) to achieve accelerated and full-label U.S. market entry, today announced the appointment of John Bencich as Chief Financial Officer. Mr. Bencich joins AEON at a pivotal stage in the Company's evolution as it prepares to execute through its next phase of critical regulatory milestones. "John's appointment represents an important step forward for AEON as we enter a period of accelerated execution," said Rob Bancroft, President and Chief Executive Officer of AEON. "His d

    3/9/26 4:05:00 PM ET
    $AEON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    PacBio Announces the Appointment of Chris Gibson to the Board of Directors

    MENLO PARK, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher Gibson, Ph.D., to PacBio's Board of Directors. Dr. Gibson is the co-founder and Chairman of the Board of Directors of Recursion (NASDAQ:RXRX), a clinical-stage biotechnology company that has built one of the industry's most advanced AI-driven drug discovery platforms. Under his leadership, Recursion integrated large-scale biological data generation with machine learning to industrialize the discovery process, building a vertically integrated technology stack spanning automation, high-dimensional b

    3/5/26 8:30:00 AM ET
    $PACB
    $RXRX
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEON
    $AMIX
    $ANGO
    $ARVN
    Financials

    Live finance-specific insights

    View All

    AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026

    AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the third quarter of fiscal year 2026 before the market open on Thursday, April 2, 2026. The Company's management will host a conference call at 8:00 am ET the same day to discuss the results. To participate in the conference call, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international). This conference call will also be webcast and can be accessed from the "Investors" section of the AngioD

    3/19/26 8:00:00 AM ET
    $ANGO
    Medical/Dental Instruments
    Health Care

    Logistic Properties of the Americas Announces Full-Year 2025 Earnings Results

    Company Accelerates Growth, Reflected in Revenue Increase of 23.3% in 4Q25 and 14.3% in 2025 NOI Increases 29.8% in 4Q25 and 11.9% for the Year Logistic Properties of the Americas (NYSE:LPA) (together with its subsidiaries, "LPA" or "the Company"), announced today its audited consolidated financial results for the year ended December 31, 2025 ("FY25"). The financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB"), which differ in certain significant respects from the U.S. Generally Accepted Accounting Principles ("GAAP"). This information sho

    3/18/26 4:33:00 PM ET
    $LPA
    Real Estate
    Finance

    ServisFirst Bancshares, Inc. Declares First Quarter Cash Dividend

    BIRMINGHAM, Ala., March 16, 2026 (GLOBE NEWSWIRE) -- ServisFirst Bancshares, Inc., (NYSE:SFBS) ("ServisFirst"), the holding company for ServisFirst Bank, today announces: At a meeting held on March 16, 2026, its Board of Directors declared a quarterly cash dividend of $0.38 per share, payable on April 13, 2026, to stockholders of record as of April 1, 2026.   About ServisFirst Bancshares, Inc. ServisFirst Bancshares, Inc. is a bank holding company based in Birmingham, Alabama. Through its subsidiary ServisFirst Bank, ServisFirst Bancshares, Inc. provides business and personal financial services from locations in Alabama, Florida, Georgia, North and South Carolina, Tennessee, Texas an

    3/16/26 4:47:00 PM ET
    $SFBS
    Major Banks
    Finance

    $AEON
    $AMIX
    $ANGO
    $ARVN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Newegg Commerce Inc.

    SC 13D/A - Newegg Commerce, Inc. (0001474627) (Subject)

    12/17/24 4:37:51 PM ET
    $NEGG
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13D filed by Zeo Energy Corporation

    SC 13D - Zeo Energy Corp. (0001865506) (Subject)

    12/6/24 5:03:15 PM ET
    $ZEO
    Industrial Machinery/Components
    Miscellaneous